Abstract
Protein and peptide are biomolecules that determine and control biological functions, thereby playing a significant role in treating various pathological conditions. Current research focuses on the development of dosage form for efficient delivery of proteins and peptides. Characteristics of biomolecules make them challenging therapeutic agents to formulate and to deliver. Stability of protein and peptide molecules is a preliminary requirement, ranging from development of dosage form to availability of drug at the site of action. The most convenient oral route is not suitable to deliver protein and peptide molecules due to poor stability of drug in harsh gastric environment. Parenteral route has the potential application to deliver biomolecules, and circumvent drawbacks associated with oral delivery of proteins and peptides. Parenteral route can elicit pharmacological action even with minimal dose of drug, preserving the integrity of molecules. To overcome the drawback of short half-life and patient compliance, associated with intravenous route, an alternate route has also been developed to deliver drugs. Extensive studies have been conducted to deliver protein and peptide molecules effectively using various delivery systems. Among a variety of systems, nanocarriers have emerged as a compelling tool due to very fine particle size, flexibility with a variety of dosage forms and routes of administration, and long circulatory half-life due to avoidance by reticular endothelial system. Further, nanocarriers can also deal with targeted and site-specific drug delivery. Physicochemical properties of biomolecules play a vital role in the selection of polymer, method of preparation, kind of carrier molecules, and drug delivery system to be used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal H, Thacker N, Misra A (2011) Parenteral delivery of peptides and proteins. In: Challenges in delivery of therapeutic genomics and proteomics. Elsevier, Amsterdam, pp 531–622
Alcalá-Alcalá S, Urbán-Morlán Z, Aguilar-Rosas I et al (2013) A biodegradable polymeric system for peptide–protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process. Int J Nanomedicine 8:2141
Cao SJ, Xu S, Wang HM et al (2019) Nanoparticles: oral delivery for protein and peptide drugs. AAPS PharmSciTech 20(5):190
Chen T, Li S, Zhu W et al (2019) Self-assembly pH-sensitive chitosan/alginate coated polyelectrolyte complexes for oral delivery of insulin. J Microencapsul 36(1):96–107
Deb PK, Ahmad J, Dina ER et al (2014) Molecular docking studies and comparative binding mode analysis of FDA approved HIV protease inhibitors. Asian J Chem 26:6227–6232
Du AW, Stenzel MH (2014) Drug carriers for the delivery of therapeutic peptides. Biomacromolecules 15(4):1097–1114
Dwivedi N, Arunagirinathan MA, Sharma S et al (2010) Silica-coated liposomes for insulin delivery. J Nanomater 2010:652048
Florence AT, Attwood D (2011) Peptides, proteins and other biopharmaceuticals. In: Physicochemical principles of pharmacy. Pharmaceutical Press Pub, London, pp 451–476
Gu Z, Aimetti AA, Wang Q et al (2013) Injectable nano-network for glucose-mediated insulin delivery. ACS Nano 7(5):4194–4201
Gulfam M, Kim JE, Lee JM et al (2012) Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells. Langmuir 28(21):8216–8223
Hamman JH, Steenekamp JH (2011) Oral peptide drug delivery: strategies to overcome challenges. In: Peptide drug discovery and development: translational research in academia and industry. Wiley, Weinheim, pp 71–90
Hamman JH, Enslin GM, Kotzé AF et al (2005) Oral delivery of peptide drugs. Bio Drugs 19(3):165–177
Iwanaga K, Ono S, Narioka K et al (1999) Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome’s surface on the GI transit of insulin. J Pharm Sci 88(2):248–252
Jain D, Mahammad SS, Singh PP et al (2019) A review on parenteral delivery of peptides and proteins. Drug Dev Ind Pharm 45(9):1403–1420
Kaintura R, Sharma P, Singh S et al (2015) Gelatin nanoparticles as a delivery system for proteins. J Nanomed Res 2(1):1–3
Lamson NG, Berger A, Fein KC et al (2020) Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. Nat Biomed Eng 4(1):84–96
Lin YH, Mi FL, Chen CT et al (2007) Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8(1):146–152
Liu C, Kou Y, Zhang X et al (2019) Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex. Int J Pharm 554:36–47
Mahato RI, Narang AS, Thoma L et al (2003) Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 20(2–3):153–214
Makhlof A, Tozuka Y, Takeuchi H (2011) Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42(5):445–451
Mandal A, Pal D, Agrahari V et al (2018) Ocular delivery of proteins and peptides: challenges and novel formulation approaches. Adv Drug Deliv Rev 126:67–95
Mansoor S, Kondiah PP, Choonara YE et al (2019) Polymer-based nanoparticle strategies for insulin delivery. Polymers 11(9):1380
Mirshahi T, Irache JM, Nicolas C et al (2002) Adaptive immune responses of legumin nanoparticles. J Drug Target 10(8):625–631
Momoh MA, Franklin KC, Agbo CP et al (2020) Microemulsion-based approach for oral delivery of insulin: formulation design and characterization. Heliyon 6(3):e03650
Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11(19–20):905–910
Mukhopadhyay P, Mishra R, Rana D et al (2012) Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review. Prog Polym Sci 37(11):1457–1475
Mumuni MA, Kenechukwu FC, Ernest OC et al (2019) Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin. Heliyon 5(9):e02366
Park K, Kwon IC, Park K et al (2011) Oral protein delivery: current status and future prospect. React Funct Polym 71(3):280–287
Renukuntla J, Vadlapudi AD, Patel A et al (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447(1–2):75–93
Roberts MJ, Bentley MD, Harris JM et al (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54(4):459–476
Sarmento B, Ribeiro A, Veiga F et al (2007) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8(10):3054–3060
Shaji J, Patole V (2008) Protein and peptide drug delivery: oral approaches. Indian J Pharm Sci 70(3):269–277
Solaro R, Chiellini F, Battisti A (2010) Targeted delivery of protein drugs by nanocarriers. Materials 3(3):1928–1980
Song Y, Shi Y, Zhang L et al (2019) Synthesis of CSK-DEX-PLGA nanoparticles for the oral delivery of exenatide to improve its mucus penetration and intestinal absorption. Mol Pharm 16(2):518–532
Spangler RS (1990) Insulin administration via liposomes. Diabetes Care 13(9):911–922
Tan ML, Choong PF, Dass CR (2010) Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 31(1):184–193
Usmani SS, Bedi G, Samuel JS et al (2017) THPdb: database of FDA-approved peptide and protein therapeutics. PLoS One 12(7):e0181748
Veronese FM (2001) Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22(5):405–417
Vishwakarma P, Mishra S, Kulkarni S et al (2018) L-valine combined PLGA nanoparticles for oral insulin delivery. J Drug Deliv Ther 8(6-A):93–101
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56(5):603–618
Wu Y, MacKay JA, McDaniel JR et al (2008) Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules 10(1):19–24
Wu ZM, Ling L, Zhou LY et al (2012) Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery. Nanoscale Res Lett 7(1):1–8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gohil, D., Thirugnanasambandan, T. (2021). Nanocarriers in Protein and Peptide Drug Delivery. In: Shah, N. (eds) Nanocarriers: Drug Delivery System. Springer, Singapore. https://doi.org/10.1007/978-981-33-4497-6_14
Download citation
DOI: https://doi.org/10.1007/978-981-33-4497-6_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4496-9
Online ISBN: 978-981-33-4497-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)